Acadia Pharmaceuticals buy Cantor Fitzgerald
Start price
14.12.23
/
50%
€25.60
Target price
14.12.24
€38.21
Performance (%)
-44.82%
Price
28.08.24
€14.13
Summary
This prediction is currently active. Massive losses of -44.82% have been the result for the BUY prediction by Cantor_Fitzgerald. This prediction currently runs until 14.12.24. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Acadia Pharmaceuticals | -0.703% | -0.703% |
iShares Core DAX® | 1.560% | 2.566% |
iShares Nasdaq 100 | 0.517% | 1.894% |
iShares Nikkei 225® | 1.730% | 5.631% |
iShares S&P 500 | 1.482% | 1.594% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $42.00 price target on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€13.87
07.08.24
07.08.24
€25.62
07.08.25
07.08.25
1.88%
28.08.24
28.08.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€14.59
09.05.24
09.05.24
€34.35
09.05.25
09.05.25
-3.19%
28.08.24
28.08.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€15.79
30.04.24
30.04.24
€34.52
30.04.25
30.04.25
-6.90%
28.08.24
28.08.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€16.50
10.04.24
10.04.24
€34.38
10.04.25
10.04.25
-14.39%
28.08.24
28.08.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€21.80
28.02.24
28.02.24
€38.75
28.02.25
28.02.25
-35.21%
28.08.24
28.08.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€23.60
02.02.24
02.02.24
€38.87
02.02.25
02.02.25
-40.15%
28.08.24
28.08.24